Any molecule that contains two amino-acid residues connected by peptide linkages.
| Member | Definition | Role |
|---|
| 4-aminobenzoylglutamic acid | A dipeptide resulting from the formal condensation of the carboxylic acid group of 4-aminobenzoic acid with the amino group of L-glutamic acid. | N-(4-aminobenzoyl)-L-glutamic acid |
| abt-267 | A dipeptide derivative which is used which is in combination with dasabuvir sodium hydrate, paritaprevir and ritonavir (under the trade name Viekira Pak) for treatment of chronic hepatitis C virus genotype 1 infection as well as cirrhosis of the liver. | ombitasvir |
| Ala-Lys | A dipeptide obtained by formal condensation of the carboxy group of L-alanine with the alpha-amino group of L-lysine. | Ala-Lys |
| alacepril | | Alacepril |
| alanylalanine | | Alanyl-alanine |
| alanylalanine | A dipeptide consisting of two L-alanine units joined by a peptide linkage. | Ala-Ala zwitterion; L-alanyl-L-alanine |
| alanylglutamic acid | A dipeptide consisting of L-glutamic acid having an L-alanyl attached to its alpha-amino group | L-alanyl-L-glutamic acid |
| alanylglutamine | A dipeptide formed from L-alanyl and L-glutamine residues. | Ala-Gln zwitterion; Ala-Gln |
| alanylglycine | A dipeptide formed from L-alanyl and glycine residues. | Ala-Gly zwitterion; Ala-Gly |
| alanylphenylalanine | A dipeptide formed from L-alanyl and L-phenylalanine residues. | Ala-Phe |
| alanylproline | A dipeptide composed of L-alanine and L-proline joined by a peptide linkage. | Ala-Pro zwitterion; Ala-Pro |
| alanyltyrosine | A dipeptide composed of L-alanine and L-tyrosine joined by a peptide linkage. | Ala-Tyr |
| alanyltyrosine | A dipeptide formed from L-tyrosine and L-alanine residues. | Tyr-Ala |
| alitame | | Alitame |
| alpha-aspartylalanine | A dipeptide formed from L-alpha-aspartyl and L-valine residues. | Asp-Ala |
| alpha-glutamyltryptophan | A dipeptide composed of L-glutamic acid and L-tryptophan joined by a peptide linkage. | Glu-Trp |
| alpha-glutamyltryptophan | A dipeptide formed from L-tryptophan and L-glutamic acid residues. | Trp-Glu |
| anserine | A dipeptide comprising of beta-alanine and 3-methyl-L-histidine units. | anserine zwitterion; anserine |
| arginyl-glutamine | A dipeptide formed from L-arginyl and L-glutamine residues. | Arg-Gln |
| arginylarginine | A dipeptide formed from two L-arginine residues. | Arg-Arg |
| arginyllysine | A dipeptide formed from L-arginyl and L-leucine residues. | Arg-Lys |
| arginylproline | A dipeptide obtained by formal condensation of the carboxy group of L-arginine with the amino group of L-proline. | Arg-Pro |
| aspartame | A dipeptide obtained by formal condensation of the alpha-carboxy group of L-aspartic acid with the amino group of methyl L-phenylalaninate. Commonly used as an artificial sweetener. | aspartame zwitterion; aspartame |
| aspartyl-aspartic acid | A dipeptide formed from two L-aspartic acid units. | Asp-Asp |
| aspartyl-phenylalanine | A dipeptide formed from L-alpha-aspartyl and L-phenylalanine residues. It is obtained after the hydrolysis of aspartame in intestinal lumen. | Asp-Phe |
| aspartyl-proline | | Asp-Pro |
| aspartylglutamate | A dipeptide formed from L-alpha-aspartyl and L-glutamic acid residues. | Asp-Glu |
| aspartylglycine | A dipeptide composed of L-aspartic acid and glycine joined by a peptide linkage. | Asp-Gly |
| aspartyllysine | A dipeptide formed from L-alpha-aspartyl and L-lysine residues. | Asp-Lys |
| b 581 | A dipeptide obtained from the tetrapeptide Cys-Val-Phe-Met by reduction of the amide carbonyl groups of the Cys and Val residues. | B 581 |
| bentiromide | The dipeptide obtained by condensation of N-benzoyl-L-tyrosine with 4-aminobenzoic acid. Used as a noninvasive screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy, it is given by mouth: the amount of 4-aminobenzoic acid and its metabolites excreted in the urine is taken as a measure of the chymotrypsin-secreting activity of the pancreas. | bentiromide |
| Benzyl N-[(2S)-3-methyl-1-[[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]-1-(1,3-thiazol-2-yl)propan-2-yl]amino]pentan-2-yl]amino]-1-oxobutan-2-yl]carbamate | | Benzyl N-[(2S)-3-methyl-1-[[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]-1-(1,3-thiazol-2-yl)propan-2-yl]amino]pentan-2-yl]amino]-1-oxobutan-2-yl]carbamate |
| beta-aspartylglycine | | L-beta-aspartylglycine |
| birinapant | | Birinapant |
| brevianamide f | A pyrrolopyrazine that is hexahydropyrrolo[1,2-a]pyrazine-1,4-dione bearing an indol-3-ylmethyl substituent at position 3 (the 3S,8aS-diastereomer, obtained by formal cyclocondensation of L-tryptophan and L-proline). | brevianamide F |
| carbobenzoxyvalylphenylalanine aldehyde | A dipeptide resulting from the formal condensation of the carboxy group of N-benzyloxycarbonyl-L-valine with the amino group of L-phenylalanine aldehyde. It is a potent cell-permeable inhibitor of calpain I and II, and is also a gamma-secretase inhibitor. | Z-Val-Phe-H |
| carbocysteine-lysine | | carbocysteine-lysine |
| carnosine | A dipeptide that is the N-(beta-alanyl) derivative of L-histidine. | carnosine zwitterion; carnosine |
| chrysobactin | A catechol-type siderophore with a structure of D-lysyl-L-serine substituted on N(2) of the lysyl residue by a 2,3-dihydroxybenzoyl group. It is produced by the Gram-negative bacillus Dickeya dadantii (previously known as Erwinia chrysanthem). Only the catecholate hydroxyl groups participate in metal coordination, so chrysobactin cannot provide full 1:1 coordination of Fe(III); at neutral pH and concentrations of about 0.1 mM, ferric chrysobactin exists as a mixture of bis and tris complexes. | chrysobactin |
| cyclo(leucyl-prolyl) | A homodetic cyclic peptide composed from leucyl and prolyl residues. | cyclo(L-Leu-L-Pro) |
| cysteinylcysteine | A dipeptide formed from two L-cysteine residues. | Cys-Cys |
| cysteinylglycine | A dipeptide consisting of glycine having an L-cysteinyl attached to its alpha-amino group. It is an intermediate metabolite in glutathione metabolism. | L-cysteinylglycine zwitterion; L-cysteinylglycine |
| cysteinylproline | A dipeptide composed of L-cysteine and L-proline joined by a peptide linkage. | Cys-Pro |
| cysteinyltyrosine | | Cys-Tyr |
| enalapril | A dicarboxylic acid monoester that is ethyl 4-phenylbutanoate in which a hydrogen alpha to the carboxy group is substituted by the amino group of L-alanyl-L-proline (S-configuration). | enalapril |
| enalaprilat anhydrous | Enalapril in which the ethyl ester group has been hydrolysed to the corresponding carboxylic acid. Enalaprilat is an angiotensin-converting enzyme (ACE) inhibitor and is used (often in the form of its prodrug, enalapril) in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients. Unlike enalapril, enalaprilat is not absorbed by mouth but is given by intravenous injection, usually as the dihydrate. | enalaprilat (anhydrous) |
| epelsiban | | Epelsiban |
| Ethyl (E,4S)-4-[[(2S)-2-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-3-phenylpropanoyl]amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate | | Ethyl (E,4S)-4-[[(2S)-2-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-3-phenylpropanoyl]amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate |
| gamma-glu-asp | | gamma-Glutamylaspartic acid |
| gamma-glutamylglutamate | A dipeptide obtained by formal condensation of the gamma-carboxy group of glutamic acid with the amino group of another glutamic acid. | gamma-Glu-Glu |
| gamma-glutamylglutamine | A dipeptide obtained by formal condensation of the gamma-carboxy group of glutamic acid with the amino group of glutamine | gamma-Glu-Gln |
| gamma-glutamylphenylalanine | A dipeptide obtained by formal condensation of the side-chain carboxy group of L-glutamic acid with the amino group of L-phenylalanine. | gamma-Glu-Phe |
| gamma-glutamyltyrosine | A dipeptide composed of L-glutamic acid and L-tyrosine joined by a peptide linkage. | gamma-Glu-Tyr |
| gap 134 | | danegaptide |
| gliotoxin | A pyrazinoindole with a disulfide bridge spanning a dioxo-substituted pyrazine ring; mycotoxin produced by several species of fungi. | gliotoxin |
| glutaminyl-glycine | A dipeptide formed from L-glutamine and glycine residues. | Gln-Gly |
| glutamyl-glutamic acid | A dipeptide composed of two L-glutamic acid units joined by a peptide linkage. | Glu-Glu |
| glutamylalanine | A dipeptide formed from L-alpha-glutamyl and L-alanine residues. | Glu-Ala |
| glutaurine | A dipeptide resulting from the formal condensation of the amino group of taurine with the gamma-carboxy group of L-glutamic acid. It was initially found in the parathyroid in 1980 and later in the brain of mammals. | glutaurine zwitterion; glutaurine |
| glycyl-l-phenylalanine | A dipeptide formed from glycine and L-phenylalanine residues. | Gly-Phe zwitterion; Gly-Phe |
| glycylaspartic acid | A dipeptide formed from glycyl and L-aspartic acid residues. | Gly-Asp |
| glycylglutamine | A dipeptide formed from glycine and L-glutamine residues. | Gly-Gln zwitterion; Gly-Gln |
| glycylglycine | A dipeptide formed from glycine residues. | glycylglycine zwitterion; glycylglycine |
| glycylhistidine | A dipeptide composed of glycine and L-histidine joined by a peptide linkage. | Gly-His zwitterion; Gly-His |
| glycylleucine | A dipeptide composed of glycine and L-leucine joined by a peptide linkage. | Gly-Leu; glycyl-L-leucine zwitterion |
| glycyllysine | A dipeptide formed from glycine and L-lysine residues. | Gly-Lys |
| glycylphenylalanine 2-naphthylamide | An N-(2-naphthyl)carboxamide obtained by formal condensation of the carboxy group of glycyl-L-phenylalanine with the amino group of 2-naphthylamine. | glycyl-L-phenylalanine 2-naphthylamide |
| glycylproline | A dipeptide consisting of L-proline having a glycyl residue attached to its alpha-amino group. | Gly-Pro zwitterion; Gly-Pro |
| glycylsarcosine | A dipeptide obtained by formal condensation of the carboxy group of glycine with the amino group of sarcosine. | glycylsarcosine zwitterion; glycylsarcosine |
| glycyltryptophan | A dipeptide formed from glycine and L-tryptophan residues. | Gly-Trp |
| glycyltyrosine | A dipeptide composed of glycine and L-tyrosine joined by a peptide linkage. | Gly-Tyr |
| glycylvaline | A dipeptide formed from glycine and L-valine residues. | Gly-Val |
| golotimod | | Golotimod |
| gsk221149a | | Retosiban |
| histidinoalanine | A dipeptide formed from L-histidine and L-alanine residues. | His-Ala zwitterion; His-Ala |
| histidyl-proline diketopiperazine | A homodetic cyclic peptide resulting from the formal condensation of both the amino and acid groups of L-histidine with the acid and amino groups of L-proline. It is a metabolite of thyrotropin-releasing hormone (TRH). | cyclo(L-His-L-Pro) |
| histidylglycine | A dipeptide formed from L-histidine and glycine residues. | His-Gly |
| histidylhistidine | A dipeptide formed from two L-histidine residues. | His-His |
| histidylleucine | A dipeptide formed from L-histidine and L-leucine residues. | His-Leu zwitterion; His-Leu |
| histidylphenylalanine | A dipeptide obtained by formal condensation of the carboxy group of L-histidine with the amino group of L-phenylalanine. | His-Phe |
| histidylproline | A dipeptide formed from L-histidine and L-proline residues. | His-Pro zwitterion; His-Pro |
| homocarnosine | A homocarnosine that has S configuration. | L-homocarnosine zwitterion; L-homocarnosine |
| id | | Isoleucyl-Aspartate |
| imidapril | A member of the class of imidazolidines that is (4S)-1-methyl-2-oxoimidazolidine-4-carboxylic acid in which the hydrogen of the imidazolidine nitrogen has been substituted by (1S)-1-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}ethyl group. It is the prodrug for imidaprilat, an ACE inhibitor used for the treatment of chronic heart failure. | imidapril |
| imidapril | | Imidapril hydrochloride |
| imidaprilat | A member of the class of imidazolidines that is imidapril in which the ethyl ester group has been hydrolysed to the corresponding acid group. It is the active metabolite of imidapril used to treat hypertension. | imidaprilat |
| isoleucyl-tyrosine | A dipeptide formed from L-isoleucine and L-tyrosine residues. | Ile-Tyr |
| isoleucylvaline | A dipeptide formed from L-isoleucine and L-valine residues. | Ile-Val |
| isospaglumic acid | A dipeptide composed of N-acetyl-L-aspartic acid and L-glutamic acid joined by a peptide linkage. | Ac-Asp-Glu |
| kyotorphin | A dipeptide composed of L-tyrosine and L-arginine joined by a peptide linkage. | Tyr-Arg |
| l-ala-gamma-d-glu-meso-diaminopimelic acid | | L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptanedioate |
| leucyl-alanine | A dipeptide composed of L-leucine and L-alanine joined by a peptide linkage. | Leu-Ala |
| leucyl-phenylalanine | A dipeptide formed from L-leucine and L-phenylalanine residues. | Leu-Phe |
| leucylarginine | A dipeptide composed of L-leucine and L-arginine joined by peptide linkages. | Leu-Arg |
| leucylleucine | A dipeptide formed from two L-leucine residues. | Leu-Leu zwitterion; Leu-Leu |
| leucylproline | A dipeptide formed from L-leucine and L-proline residues. | Leu-Pro zwitterion; Leu-Pro |
| leucyltyrosine | A dipeptide formed from L-leucine and L-tyrosine residues. | Leu-Tyr |
| leukotriene d4 | A leukotriene that is (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid substituted by a hydroxy group at position 5 (5S) and a L-cysteinylglycinyl group at position 6 (6R). | leukotriene D4 |
| leukotriene f-4 | A leukotriene composed of (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid having (5S)-hydroxy and (6R)-(L-gamma-glutamyl-L-cystein-S-yl) substituents. | leukotriene F4 |
| libenzapril | | libenzapril |
| lisinopril | | lisinopril |
| lysylglutamic acid | A dipeptide formed from L-lysine and L-glutamic acid residues. | Lys-Glu |
| lysylglycine | A dipeptide formed from L-lysine and glycine residues. | Lys-Gly |
| lysyllysine | A dipeptide formed from two L-lysine residues. | Lys-Lys |
| lysylproline | A dipeptide formed from L-lysine and L-proline residues. | Lys-Pro |
| maculosin | A homodetic cyclic peptide that is a dipeptide composed of L-proline and L-tyrosine joined by peptide linkages. | maculosin |
| methionylglutamic acid | A dipeptide formed from L-methionine and L-glutamic acid residues. | Met-Glu |
| methionylglycine | A dipeptide formed from L-methionine and glycine residues. | Met-Gly |
| methionyltryptophan | A dipeptide formed from L-methionine and L-tryptophan residues. | Met-Trp |
| moexipril hydrochloride | | Moexipril hydrochloride |
| n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | A dipeptide consisting of alanylphenylglycine derivatised as a 3,5-difluorophenylacetamide at the amino terminal and a tert-butyl ester at the carboxy terminal. A gamma-secretase inhibitor. | DAPT |
| n-acetyl-beta-glucosaminyl-n-acetylmuramyl-alanylisoglutamine | | glucosaminylmuramyl dipeptide |
| n-acetylcarnosine | A dipeptide that is the N-acetyl derivative of carnosine. | N-acetylcarnosine |
| n-acetylglutaminylglutamine amide | | N2-Acetyl-L-glutaminyl-L-glutamamide |
| n-glycylalanine | A dipeptide formed from glycine and L-alanine residues. | Gly-Ala |
| n-glycylglutamic acid | A dipeptide formed from glycyl and L-glutamic acid residues. | Gly-Glu |
| neotame | A dipeptide composed of N-(3,3-dimethylbutyl)-L-aspartic acid and methyl L-phenylalanate units joined by a peptide linkage. | neotame |
| omapatrilat | | omapatrilat |
| perindoprilat | A dipeptide obtained by formal condensation of one of the carboxy groups of N-[(1S)-1-carboxyethyl]-L-norvaline with the amino group of (2S,3aS,7aS)-octahydroindole-2-carboxylic acid. The major active metabolite of perindopril. | perindoprilat |
| Phe-Tyr | A dipeptide formed from L-phenylalanine and L-tyrosine residues. | Phe-Tyr |
| phenylalanyl-valine | A dipeptide formed from L-valine and L-phenylalanine residues. | Val-Phe |
| phenylalanyl-valine | A dipeptide formed from L-phenylalanine and L-valine residues. | Phe-Val |
| phenylalanylalanine | A dipeptide formed from L-phenylalanine and L-alanine residues. | Phe-Ala zwitterion; Phe-Ala |
| phenylalanylarginine | A dipeptide composed of L-phenylalanine and L-arginine joined by a peptide linkage. | Phe-Arg |
| phenylalanylglutamate | A dipeptide formed from L-phenylalanine and L-glutamic acid residues. | Phe-Glu |
| phenylalanylglycine | A dipeptide formed from L-phenylalanine and glycine residues. | Phe-Gly |
| phenylalanylleucine | A dipeptide obtained by formal condensation of the carboxy group of L-phenylalanine with the amino group of L-leucine. | Phe-Leu zwitterion; Phe-Leu |
| phenylalanylphenylalanine | A dipeptide formed from two L-phenylalanine residues. | Phe-Phe zwitterion; Phe-Phe |
| phenylalanylproline | A dipeptide formed from L-phenylalanine and L-proline residues. | Phe-Pro |
| phenylalanylserine | A dipeptide that is the N-(L-phenylalanyl) derivative of L-serine. | Phe-Ser |
| phosphoramidon | A dipeptide isolated from the cultures of Streptomyces tanashiensis. | phosphoramidon |
| prolyl-4-hydroxyproline | | Prolyl-Hydroxyproline |
| prolyl-proline | A dipeptide formed from two L-proline residues. | Pro-Pro |
| prolyl-serine | A dipeptide formed from L-proline and L-serine residues. | Pro-Ser |
| prolyl-tyrosine | A dipeptide formed from L-proline and L-tyrosine residues. | Pro-Tyr |
| prolylarginine | A dipeptide formed from L-proline and L-arginine residues. | Pro-Arg |
| prolylglutamic acid | A dipeptide formed from L-proline and L-glutamic acid residues. | Pro-Glu |
| prolylglycine | A dipeptide consisting of glycine having an L-prolyl group attached to its alpha-amino nitrogen. | L-prolinylglycine zwitterion; L-prolylglycine |
| prolylisoleucine | A dipeptide formed from L-proline and L-isoleucine residues. | Pro-Ile |
| prolylvaline | A dipeptide formed from L-valine and L-proline residues. | Val-Pro |
| pyroglutamylleucine | | Pyroglutamylleucine |
| ramipril | A dipeptide that is the prodrug for ramiprilat, the active metabolite obtained by hydrolysis of the ethyl ester group. An angiotensin-converting enzyme (ACE) inhibitor, used to treat high blood pressure and congestive heart failure. | ramipril |
| ramiprilat | A dipeptide that is the active metabolite of ramipril. An angiotensin-converting enzyme (ACE) inhibitor, used to treat high blood pressure and congestive heart failure. | ramiprilat |
| RF9 | A dipeptide formed from L-arginine and L-phenylalaninamide residues in which a hydrogen attached to the nitrogen of the alpha-amino group of the arginine residue has been replaced by a 1-adamantanecarbonyl group. It has been reported to be a potent and selective antagonist of neuropeptide FF (NPFF) receptors, but more recently found to be an agonist at both NPFF1R and the kisspeptin receptor (KISS1R). | RF9 |
| s-nitrosocysteinylglycine | A dipeptide resulting from the formal condensation of the carboxylic acid group of S-nitroso-L-cysteine with the amino group of glycine. | S-nitroso-L-cysteinylglycine |
| seryl-histidine | A dipeptide formed from L-serine and L-histidine residues. | Ser-His |
| seryl-proline | A dipeptide formed from L-serine and L-proline residues. | Ser-Pro |
| spirapril | | spirapril |
| spiraprilat | An azaspiro compound that is spirapril in which the ethyl ester group has been hydrolysed to the corresponding carboxylic acid group. It is the active metabolite of the angiotensin-converting enzyme (ACE) inhibitor spirapril. | spiraprilat |
| syringolin a | | 2-(3-(1-(((4E,10E)-2,9-Dioxo-12-isopropyl-1,8-diazacyclododecane-4,10-diene-3-yl)carbamoyl)-2-methylpropyl)ureido)-3-methylbutyric acid |
| tabtoxin | A monobactam phytotoxic dipeptide produced by Pseudomonas syringae, that causes wildfire disease in tobacco. | tabtoxin |
| temocapril | | temocapril |
| temocapril hydrochloride | | Temocapril hydrochloride |
| trandolapril | A heterobicylic compound that is (2S,3aR,7aS)-1-[(2S)-2-aminopropanoyl]octahydro-1H-indole-2-carboxylic acid in which the hydrogen of the amino group is substituted by a (2R)-1-ethoxy-1-oxo-4-phenylbutan-2-yl group. It is a angiotensin-converting enzyme inhibitor and a prodrug used for the treatment of hypertension. | trandolapril |
| trandolaprilat | A heterobicyclic compound that is trandolapril in which the ethyl ester group has been hydrolysed to the corresponding acid group. It is the active metabolite of the prodrug trandolapril. | trandolaprilat |
| Trp-Trp | A dipeptide formed from two L-tryptophan residues. | Trp-Trp |
| tryprostatin a | A cyclic dipeptide that is brevianamide F (cyclo-L-Trp-L-Pro) substituted at positions 2 and 6 on the indole ring by prenyl and methoxy groups respectively. | tryprostatin A |
| tryprostatin b | A cyclic dipeptide that is brevianamide F (cyclo-L-Trp-L-Pro) substituted at position 2 on the indole ring by a prenyl group. | tryprostatin B |
| tryptophylglycine | A dipeptide formed from L-tryptophan and glycine residues. | Trp-Gly |
| tyropeptin a | | Tyropeptin A |
| tyrosyl-proline | | Tyrosyl-Proline |
| tyrosylleucine | A dipeptide formed from L-tyrosine and L-leucine residues. | Tyr-Leu |
| u-47929 | | ficellomycin |
| valylleucine | A dipeptide formed from L-valine and L-leucine residues. | Val-Leu |
| valyltyrosine | A dipeptide formed from L-valine and L-tyrosine residues. | Val-Tyr |
| valylvaline | A dipeptide formed from two L-valine residues. | Val-Val |
| vanchrobactin | A catechol-type natural product that is composed of 2,3-dihydroxybenzoic acid, D-arginine and L-serine joined in sequence by peptide linkages. It is a siderophore synthesized by the bacterial fish pathogen Vibrio anguillarum. | vanchrobactin |
| vx 765 | | Belnacasan |